Thermo Fisher Scientific (TMO) Return on Capital Employed (2009 - 2026)
Thermo Fisher Scientific (TMO) posted Return on Capital Employed of 8.12% for Q1 2026, down 4.08% quarter-over-quarter from 8.47% in Q4 2025, and down 57.0% year-on-year from 18.89% in Q1 2025.
Thermo Fisher Scientific (TMO) Return on Capital Employed (2009 - 2026) Analysis & Trends
Thermo Fisher Scientific (TMO) has reported Return on Capital Employed for 18 consecutive years, with 8.12% the latest figure, recorded in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 8.12%, down 57.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 8.12% (down 57.0% YoY), and the FY2025 annual result was 8.74%, up 8.0% from the prior year.
- Return on Capital Employed was 8.12% for Q1 2026 at Thermo Fisher Scientific, down from 8.47% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 11.97% in Q2 2022 and troughed at 8.12% in Q1 2026.
- Average Return on Capital Employed over 5 years is 9.21%, with a median of 8.58% recorded in 2024.
- Year-over-year, Return on Capital Employed sank 593 bps in 2022 and soared 41 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 10.92% in 2022, then slipped by 25 bps to 8.18% in 2023, then gained by 5 bps to 8.58% in 2024, then slipped by 1 bps to 8.47% in 2025, then decreased by 4 bps to 8.12% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 8.12% in Q1 2026, 8.47% in Q4 2025, and 8.61% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 67.98% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -3.63% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 14.57% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 45.73% |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | 11.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 8.12% |
| Dec 31, 2025 | 8.47% |
| Sep 27, 2025 | 8.61% |
| Jun 28, 2025 | 8.47% |
| Mar 29, 2025 | 8.69% |
| Dec 31, 2024 | 8.58% |
| Sep 28, 2024 | 8.46% |
| Jun 29, 2024 | 8.67% |
| Mar 30, 2024 | 8.29% |
| Dec 31, 2023 | 8.18% |
| Sep 30, 2023 | 8.43% |
| Jul 1, 2023 | 8.36% |
| Apr 1, 2023 | 8.92% |
| Dec 31, 2022 | 10.92% |
| Oct 1, 2022 | 11.42% |
| Jul 2, 2022 | 11.95% |
| Apr 2, 2022 | 11.97% |
| Dec 31, 2021 | 14.14% |
| Oct 2, 2021 | 16.79% |
| Jul 3, 2021 | 17.88% |